Get an alert when CURALEAF INTERNATIONAL LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Free · confirmation link first · unsubscribe in one click

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2026-09-28 (in 4mo)

Last made up 2025-09-14

Watchouts

None on the register

Cash

£3M

-59.2% vs 2023

Net assets

-£39M

-50.3% vs 2023

Employees

352

+12.5% vs 2023

Profit before tax

-£14M

-23.9% vs 2023

Name history

Renamed 1 time since incorporation

  1. CURALEAF INTERNATIONAL LIMITED 2021-10-20 → present
  2. EMMAC LIFE SCIENCES LIMITED 2018-03-14 → 2021-10-20

Accounts

2-year trend · latest reflected 2024-12-31

Metric Trend 2023-12-312024-12-31
Turnover £28,825,000£49,345,000
Operating profit -£11,621,000-£5,380,000
Profit before tax -£11,565,000-£14,326,000
Net profit -£11,687,000-£11,709,000
Cash £6,969,000£2,846,000
Total assets less current liabilities -£15,964,000£815,000
Net assets -£26,119,000-£39,258,000
Equity -£26,119,000-£39,258,000
Average employees 313352
Wages £13,165,000£15,012,000

Values shown as filed in the company's annual accounts. indicates the figure wasn't present under that line item in that period. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio Trend 2023-12-312024-12-31
Operating margin -40.3%-10.9%
Net margin -40.5%-23.7%
Return on capital employed 72.8%-660.1%
Gearing (liabilities / total assets) 130.0%143.2%
Current ratio 0.32x0.37x
Interest cover -2.33x-0.76x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis
IFRS
Reporting scope
Consolidated group
Auditor
PKF Littlejohn LLP
Audit opinion
Unqualified (clean)
Going concern
Affirmed

“The Directors are pleased to present the financial statements on a going concern basis. Based on the current cash balances and the confirmed ongoing financial support of the Group's parent company the Directors are confident that the Group has sufficient cash to make the necessary investments to grow the Group in line with its strategic vision and to meet the liabilities of the business as they fall due.”

Group structure

  1. CURALEAF INTERNATIONAL LIMITED · parent
    1. Curaleaf UK Limited 100% · England · Research and Development
    2. EMMAC Malta Limited 100% · Malta · Production licenses for medical cannabis
    3. EMMAC Life Sciences Espana, SL 100% · Spain · Research and Development
    4. Curaleaf Portugal Lda 100% · Portugal · Research and Development
    5. Curaleaf II Portugal Lda 100% · Portugal · Import, Manufacturing and Distribution
    6. Curaleaf Suisse SARL 100% · Switzerland · Research and Development
    7. Medalchemy S.L. 97.5% · Spain · Import, Manufacturing and Distribution.
    8. Rokshaw Limited 100% · England · Import, Manufacturing and Distribution
    9. Curaleaf Deutschland (GmBH) 100% · Germany · Holding Company
    10. Adven GmBH 100% · Germany · Import and Distribution
    11. Curaleaf International Pharma SARL 100% · Switzerland · Research & Development
    12. Curaleaf International Poland Spółka Z.O.O. 100% · Poland · Holding Company
    13. Curaleaf Poland S.A. 100% · Poland · Import and Distribution
    14. Curaleaf International Tarim Sanayi Ve Ticaret Anonim Sirket 100% · Turkey · Import and Distribution
    15. Curaleaf France SAS 100% · France · Import and Distribution
    16. Sapphire Medical Clinics Limited 100% · England · Cannabis clinics
    17. Sapphire Clinics (London) Limited 100% · England · Cannabis clinics
    18. Sapphire Clinics (Central) Limited 100% · England · Cannabis clinics
    19. Mediras Deutschland GmbH 100% · Germany · Cannabis clinics
    20. Curaleaf Italia S.r.l. 0% · Italy · Research and Development
    21. Curaleaf Cologne (GmBH) 0% · Germany · Distribution
    22. Curaleaf Pharmacy Limited 0% · UK · Cannabis clinics

Significant events

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 9 resigned

Name Role Appointed Born Nationality
GRUZDEV, Ilia Director 2025-11-28 Dec 1983 British
MARTINEZ, Juan Pablo Director 2023-12-19 Aug 1993 Spanish
Show 9 resigned officers
Name Role Appointed Resigned
ABONY, Lorne Director 2019-10-18 2021-04-07
COSTANZO, Antonio Filippo Augusto Director 2018-09-20 2022-12-31
DOONA, Peter Charles Michael Director 2022-07-13 2025-11-28
ELLEN, Thomas George Director 2019-02-06 2022-07-13
MCDERMOTT, Edward Peter Director 2018-03-14 2021-06-30
PACCHETTI, Barbara Director 2019-05-01 2022-12-22
ROOKE, Thomas Philip Kirshaw Director 2018-10-16 2023-02-21
WORNE, Miles Dymoke Director 2022-07-13 2023-12-01
YARKONI, Orr, Dr Director 2019-07-12 2021-04-07

Ownership

Persons with significant control

Name Kind Nature of control Notified Status
Mr Boris Alexis Jordan Individual Voting 50–75% 2021-04-07 Active
Mr Edward Peter Mcdermott Individual Shares 75–100%, Voting 75–100%, Appoints directors 2018-03-14 Ceased 2018-09-20

Filing timeline

Last 20 of 60 total filings

Material constitutional events — rename, articles re-file, resolution

  • 2021-10-29 MA Memorandum articles
  • 2021-10-29 RESOLUTIONS Resolution
Date Type Category Description
2025-12-02 AP01 officers Appoint person director company with name date PDF
2025-12-02 TM01 officers Termination director company with name termination date PDF
2025-10-06 AA accounts Accounts with accounts type group
2025-09-18 CS01 confirmation-statement Confirmation statement with no updates PDF
2024-10-10 AA accounts Accounts with accounts type group
2024-10-01 CS01 confirmation-statement Confirmation statement with no updates PDF
2023-12-22 AP01 officers Appoint person director company with name date PDF
2023-12-22 TM01 officers Termination director company with name termination date PDF
2023-10-11 AA accounts Accounts with accounts type group
2023-09-21 CS01 confirmation-statement Confirmation statement with updates PDF
2023-02-21 TM01 officers Termination director company with name termination date PDF
2023-01-03 TM01 officers Termination director company with name termination date PDF
2022-12-22 TM01 officers Termination director company with name termination date PDF
2022-10-12 CS01 confirmation-statement Confirmation statement with no updates PDF
2022-08-08 AP01 officers Appoint person director company with name date PDF
2022-08-08 AP01 officers Appoint person director company with name date PDF
2022-08-08 TM01 officers Termination director company with name termination date PDF
2022-05-18 AA accounts Accounts with accounts type group
2021-10-29 MA incorporation Memorandum articles
2021-10-29 RESOLUTIONS resolution Resolution

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings
4

last 12 months

Capital events
0

last 24 months

Officers appointed
1

last 12 months

Officers resigned
1

last 12 months

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Official Companies House page